Trinna L. Cuellar, PhD, MBA

Founding Scientific Advisory Board Member (sab) at Tally Health

Trinna L. Cuellar, PhD, MBA has a diverse and extensive work experience in the field of biological research and development. Trinna L. is currently serving as the Head of Research and Development/VP of Biology at Tally Health, where they oversee all research and development activities related to epigenetic tests, computational biology, interventions, and supplements. Trinna L.'srole includes the development of epigenetic aging clocks and interventions that promote longevity and healthspan.

Prior to their current position, Trinna was the Gotham Subsidiary Site Head and a member of the 858 Therapeutics Management Team at Gotham Therapeutics, a subsidiary acquired by 858 Therapeutics. Trinna L. contributed to the development of therapeutics targeting the epitrascriptomic machinery.

Trinna also held various roles at Gotham Therapeutics before its acquisition, including Senior Director of Biology and NYC Site Head. In these roles, they led the biology department and managed the research operations.

Before joining Gotham Therapeutics, Trinna worked as a Principal Investigator/Independent Scholar at Princeton University, where they received full funding and support. Trinna L.'sresearch focused on the innate immune response and integrated stress response in cancer, particularly in understanding how cancer cells evade immune detection through epigenetic modifications.

Trinna gained significant experience at Genentech, where they worked as a Principal Investigator - Epigenetics. During their time there, they received numerous awards and led a team that discovered the role of the SETDB1 methyltransferase in regulating the antiviral stress response in Acute Myeloid Leukemia cells. This finding shed light on how tumor cells hide from the host immune response.

Trinna L. began their career as a Graduate Student (Ph.D.) at the University of California, San Francisco, studying the roles of miRNAs in neuronal and glial development, neurodegeneration, and aging. Trinna L.'sresearch resulted in multiple publications.

Trinna's early research experience includes studying neurodegenerative disorders and aging at Drexel University, with a focus on the role of metabolism in Alzheimer's disease and the role of insulin signaling in APP processing.

Trinna L. also completed internships at GSK, where they worked in various groups studying therapeutic immune proteins, comparative genomics, and cell cultures.

Overall, Trinna L. Cuellar has demonstrated expertise in leading research and development teams and conducting groundbreaking research in the field of biology and epigenetics.

Trinna L. Cuellar, PhD, MBA has a diverse education history. Trinna L. obtained their Master of Business Administration (MBA) degree from the MIT Sloan School of Management between 2019 and 2021. Prior to that, they pursued a Doctor of Philosophy (PhD) in Biomedical Sciences from the University of California, San Francisco from 2004 to 2009.

Trinna also holds a Bachelor of Science (BSc) degree in Molecular Biology from Drexel University, which they completed in 2003. During their time at Drexel, they participated in the 5-Year Cooperative Internship Program, which included three separate 6-month internships at GSK. While pursuing their BSc in Biology at Drexel University, Trinna cross-enrolled at the University of Pennsylvania, further expanding their knowledge by studying Psychology.

In addition to their extensive academic background, Trinna has obtained several certifications. Trinna L. is an Advanced Open Water Diver, Enriched Air Diver, and Open Water Diver, all certified by PADI, with the most recent certifications obtained in December 2022 and January 2022. Trinna has also completed the R Programming certification from Johns Hopkins University through Coursera in May 2014. Furthermore, they hold an Amateur Radio License (HAM radio Technician) certified by the FCC since September 2014. Trinna also obtained the gCERT (Genentech Community Emergency Response Team) certification, although specific details about the institution and the year are unavailable.

Trinna's educational and certification background demonstrates their commitment to acquiring knowledge and expanding their expertise in various fields, including business administration, biomedical sciences, molecular biology, psychology, programming, scuba diving, and emergency response.


Previous companies

Genentech logo
Gotham Therapeutics logo


  • Founding Scientific Advisory Board Member (sab)

    May 1, 2024 - present

  • Head of Research and Development/VP of Biology

    January, 2022

A panel showing how The Org can help with contacting the right person.